EchoSolv AS vs 1CMR Pro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

EchoSolv AS

by Echo IQ

1CMR Pro

by Mycardium AI Limited

AI Verdict

EchoSolv AS is an AI-powered clinical decision support platform specifically designed to identify patients at risk for severe aortic stenosis using echocardiogram measurements. In contrast, 1CMR Pro is an AI-enhanced software for cardiac MRI reporting, focusing on automated, precise volumetric and functional measurements across various cardiac conditions. While both are cardiology AI tools, they address different imaging modalities and distinct clinical applications, making them complementary rather than direct competitors.

Choose EchoSolv AS if…

Choose EchoSolv AS if your primary goal is to rapidly and accurately identify patients at high risk for severe aortic stenosis using existing echocardiogram measurements. This cloud-based platform is ideal for providing ultra-fast, AI-powered clinical decision support and second reader assistance, integrating seamlessly with PACS to prioritize studies without requiring extensive EMR integration.

View EchoSolv AS →

Choose 1CMR Pro if…

Choose 1CMR Pro if your institution requires highly precise and consistent AI-enhanced reporting for Cardiac MRI studies, particularly for automated volumetric and functional measurements. This on-premise solution is best suited for environments prioritizing local data processing and seeking to significantly improve the accuracy and efficiency of CMR analysis with clinician-controlled, editable contours.

View 1CMR Pro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	EchoSolv AS	1CMR Pro
Pricing	Unknown	Contact for pricing
Deployment	Cloud-based	On-premise (software installed on hospital's own computer, processing data locally via a secure web-based platform)
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoSolv AS

EchoSolv AS (Tool A) emphasizes seamless integration into existing PACS workflows without requiring EMR integration, which simplifies deployment and adoption. Its ultra-fast risk detection in under 3 seconds also contributes to a more efficient and user-friendly experience.

Clinical Value

1CMR Pro

1CMR Pro (Tool B) offers a significant clinical advantage by delivering up to 40% more precise measurements in Cardiac MRI analysis, which can lead to more accurate diagnoses across various cardiac conditions. Its validation across multi-center datasets and use of extensive training data further bolster its clinical reliability.

Pricing & Value

Tie

Neither tool provides publicly disclosed pricing information in the structured facts or through web searches. Both are likely enterprise-focused solutions, making a direct comparison of their pricing and value proposition impossible without further details.

Enterprise Readiness

EchoSolv AS

EchoSolv AS (Tool A) explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA), which are crucial for enterprise adoption in the US healthcare system. While 1CMR Pro (Tool B) mentions local data processing and ISO 27001 certification, its HIPAA compliance and BAA are not explicitly stated.

Innovation

1CMR Pro

1CMR Pro (Tool B) demonstrates a higher degree of innovation by leveraging convolutional neural networks trained on extensive datasets (700,000 cine images, 60,000 expert segmentations) to achieve up to 40% higher precision in fundamental cardiac MRI measurements. This foundational improvement in imaging analysis has broader implications for diagnostic accuracy.

Support & Docs

Tie

Neither the provided JSON data nor web searches yielded specific details regarding the level of support or documentation available for either EchoSolv AS or 1CMR Pro. Therefore, it is not possible to distinguish between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	EchoSolv AS	1CMR Pro
Name	EchoSolv AS	1CMR Pro
Company	Echo IQ	Mycardium AI Limited
Description	EchoSolv AS is an FDA-cleared, AI-powered clinical decision support platform by Echo IQ that analyzes echocardiograms to identify patients at risk for severe aortic stenosis with high accuracy and efficiency, integrating into existing workflows.	1CMR Pro by Mycardium AI is an FDA 510(k) cleared and CE Class IIB cleared AI-enhanced Cardiac MRI reporting software that delivers up to 40% more precise measurements, enabling faster and more consistent cardiac MRI analysis.
Primary Modality	Echocardiograms	Cardiac MRI
Key Function	Identify high-probability severe aortic stenosis (sAS) patients	AI-enhanced Cardiac MRI Reporting with automated volumetric and functional measurements
Specialties	Cardiology, Cardiothoracic Surgery	Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring EchoSolv AS and 1CMR Pro.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific imaging modalities and clinical conditions do these AI tools address?

EchoSolv AS is an AI-powered clinical decision support platform that analyzes echocardiograms to identify patients at risk for severe aortic stenosis. In contrast, 1CMR Pro is an AI-enhanced software specifically designed for Cardiac MRI reporting, focusing on improving the precision and consistency of measurements.

What are the key differences in how their AI processes data?

EchoSolv AS's AI analyzes numerical measurements from echocardiograms, not images, and does not use LVOT measurements to identify severe aortic stenosis probability. 1CMR Pro utilizes convolutional neural networks trained on extensive datasets of cine images and expert segmentations to provide automated volumetric and functional measurements for Cardiac MRI.

What are the stated regulatory clearances and data privacy assurances for each tool?

EchoSolv AS is FDA-cleared, HIPAA compliant, and explicitly states it has a Business Associate Agreement (BAA). 1CMR Pro is FDA 510(k) cleared and CE Class IIB cleared, and while HIPAA compliance is considered likely due to local data processing and ISO 27001 certification, an explicit HIPAA compliance statement for 1CMR Pro and BAA status are not explicitly stated.

How do these tools integrate into existing clinical workflows?

EchoSolv AS is designed to fit existing workflows by integrating with PACS and does not require EMR integration. 1CMR Pro is installed on the hospital's own computer and processes data locally via a secure web-based platform for Cardiac MRI reporting.

What are the primary benefits in terms of speed and precision offered by each tool?

EchoSolv AS offers ultra-fast risk detection for severe aortic stenosis, completing analysis in under 3 seconds. 1CMR Pro delivers up to 40% more precise measurements than manual analysis, enhancing the speed, accuracy, and consistency of Cardiac MRI analysis.

Which medical specialties are these tools primarily designed for?

EchoSolv AS is primarily aimed at Cardiology and Cardiothoracic Surgery specialties. 1CMR Pro is designed for use within Cardiology and Radiology departments.